1、现代肿瘤医学2 0 2 3年11月第31卷第2 2 期9LI P,QIN P,FU X,et al.Associations between peripheral bloodlymphocyte subsets and clinical outcomes in patients with lungcancer treated with immune checkpoint inhibitor J.Ann PalliatMed,2021,10(3):3039-3049.10 HUANG DD,WU GF,LUO X,et al.Value of muscle quality,strength an
2、d gait speed in supporting the predictive power ofGLIM-defined malnutrition for postoperative outcomes in over-weight patients with gastric cancer J.Clin Nutr,2021,40(6):42014208.11 金明,蒋敬庭.PNI与SII在胃癌患者术后预测生存中的价值J.临床检验杂志,2 0 2 2,40(0 9):6 57-6 6 1.JIN M,JIANG JT.Value of PNI and SII in predicting the
3、 survivalof gastric cancer patients after surgery J.Journal of Clinical Ex-amination,2022,40(09):657-661.12 SUN H,CHEN L,HUANG R,et al.Prognostic nutritional indexfor predicting the clinical outcomes of patients with gastric cancerwho received immune checkpoint inhibitors J.Front Nutr,2022,9:1038118
4、.13 吴清云,邹小明.胃癌切除术后并发症的术前预测因素分析J.现代肿瘤医学,2 0 2 2,30(14)2 6 6 2-2 6 6 7WU QY,ZOU XM.Analysis of preoperative predictors of compli-cations after gastric gastrectomy J.Modern Oncology,2022,30(14):2662-2667.14 KIM KW,LEE K,LEE JB,et al.Preoperative nutritional risk in-dex and postoperative one-year skelet
5、al muscle loss can predictthe prognosis of patients with gastric adenocarcinoma:a registry-based studyJ.BMC Cancer,2021,21(1):1-11.15 孙政,阙海峰,楼建,等.营养风险指数在IV期胃癌预后评价中的意义J.临床外科杂志,2 0 2 2,30(0 1):58-6 1.SUN Z,QUE HF,LOU J,et al.Significance of the nutritional riskindex in the prognosis evaluation of stag
6、e gastric cancer J.Jour-nal of Clinical Surgery,2022,30(01):58-61.16WANG P,CHEN X,LIU Q,et al.Application of four nutritionalrisk indexes in perioperative management for esophageal cancerpatients J.J Cancer Res Clin,2021,147:3099-3111.17BAO X,LIU F,LIN J,et al.Nutritional assessment and prognosisof
7、oral cancer patients:a large-scale prospective study J.BMCCancer,2020,20(1):146.18 ZHU J,FANG R,PAN Z,et al.Cireulating lymphocyte subsets areMODERN ONCOLOGY,Nov.2023,VOL.31,No.2219 2ZHOU J,LIN HP,XU X,et al.The predictive value of peripheralblood cells and lymphocyte subsets in oesophageal squamous
8、 cellcancer patients with neoadjuvant chemoradiotherapy J.FrontImmunol,2022,13:1041126.20GAO C,TONG YX,ZHU L,et al.Short-term prognostic role ofperipheral lymphocyte subsets in patients with gastric cancer J.Int Immunopharmacol,2023,115:109641.21LIF,SUN Y,HUANG J,et al.CD4/CD8+T cells,DC subsets,Fox
9、p3,and IDO expression are predictive indictors of gastric canc-er prognosis JJ.Cancer Medicine,2019,8(17):7330-7344.22LI X,DING Y,ZI M,et al.CD19,from bench to bedsideJ.Im-munol Lett,2017,183:86-95.23 CHEN VE,GREENBERGER BA,TAYLOR JM,et al.The under-appreciated role of the humoral immune system and
10、B cells in tu-morigenesis and cancer therapeutics:A review J.Int J RadiatOncol,2020,108(1):38-45.24CONEJO-GARCIA JR,BISWAS S,CHAURIO R.Humoral im-mune responses:Unsung heroes of the war on cancer J.SeminImmunol,2020,49:101419.25 ZAENKER P,GRAY ES,ZIMAN MR.Autoantibody production incancer-the humoral
11、 immune response toward autologous antigensin cancer patientsJ.Autoimmun Rev,2016,15(5):477-483.26SATO Y,SHIMODA M,SOTA Y,et al.Enhanced humoral immu-nity in breast cancer patients with high serum concentration of anti-HER2 autoantibody J.Cancer Medicine,2021,10(4):1418-1430.27ZHANG Q,ZHANG L,JIN Q,
12、et al.The prognostic value of theGNRI in patients with stomach cancer undergoing surgeryJ.JPers Med,2023,13(1):155.28ALWARAWRAH Y,KIERNAN K,MACIVER NJ.Changes in nu-tritional status impact immune cell metabolism and function J.Front Immunol,2018,9:1055.29BITO R,HINO S,BABA A,et al.Degradation of oxi
13、dative stress-induced denatured albumin in rat liver endothelial cells J.Am J Physiol,2005,289(3):C531-C542.(编校:蔺玥):4201:prognostic factors in patients with nasopharyngeal carcinoma J.BMC Cancer,2022,22(1):716.关于统计学符号规范化书写的要求根据国家标准CB3358-93统计学术语的有关规定,作者在书写统计学符号时应注意以下要求:样本的算术平均数用英文小写x,不用大写X也不用Mean或M;标准差用英文小写s,不用SD;标准误用英文小写s不用SE;t检验用英文小写t;F检验用英文大写F;卡方检验用希文小写X;相关系数用英文小写r;自由度用希文小V;样本数用英文小写n;概率用英文大写P;以上符号xsst、FVVn、P均为斜体。现代肿瘤医学编辑部
©2010-2024 宁波自信网络信息技术有限公司 版权所有
客服电话:4008-655-100 投诉/维权电话:4009-655-100